Proximity of Immune and Tumor Cells Underlies Response to BRAF/MEK-Targeted Therapies in Metastatic Melanoma Patients

In a TCGA-melanoma dataset, tumor cellularity exhibited additive prognostic value in the immune score signature to predict overall survival in patients with early-stage melanoma.